Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma

Growing evidence indicates a link between retinoic acid (RA) metabolism and sarcoma progression or immunity in laboratory studies. However, a comprehensive analysis of RA abnormality in the sarcoma population is still lacking. Herein, we systematically analyzed the molecular features of 19 retinoic...

Full description

Bibliographic Details
Main Authors: HuaiYuan Xu, JinXin Hu, YiJiang Song, HongMin Chen, YanYang Xu, ChuangZhong Deng, Hao Wu, GuoHui Song, JinChang Lu, QinLian Tang, LiangPing Xia, Jin Wang, XiaoJun Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.780951/full
_version_ 1818082902996418560
author HuaiYuan Xu
JinXin Hu
YiJiang Song
HongMin Chen
YanYang Xu
ChuangZhong Deng
Hao Wu
GuoHui Song
JinChang Lu
QinLian Tang
LiangPing Xia
Jin Wang
XiaoJun Zhu
author_facet HuaiYuan Xu
JinXin Hu
YiJiang Song
HongMin Chen
YanYang Xu
ChuangZhong Deng
Hao Wu
GuoHui Song
JinChang Lu
QinLian Tang
LiangPing Xia
Jin Wang
XiaoJun Zhu
author_sort HuaiYuan Xu
collection DOAJ
description Growing evidence indicates a link between retinoic acid (RA) metabolism and sarcoma progression or immunity in laboratory studies. However, a comprehensive analysis of RA abnormality in the sarcoma population is still lacking. Herein, we systematically analyzed the molecular features of 19 retinoic acid metabolism-related enzymes and sarcoma patients’ clinical information based on TCGA/TARGET/GSE datasets. We identified two RA expression subtypes, which were related to distinct clinical survival outcomes and exhibited different biological features. Gene set enrichment analysis indicated a set of immune pathways were enriched in G1 while oncogenic pathways were enriched in G2. Immune cell infiltration analysis using the TIMER algorithm revealed more CD4+ and CD8+ T cell infiltration in G1 subgroups than in G2. Moreover, we generated a seven genes signature to predict the RA metabolism index based on the LASSO-penalized Cox regression model. Survival analysis demonstrated the significant prognostic differences between high- and low-risk groups among different bone and soft tissue datasets. A higher risk index was associated with less T cell CD8+ infiltration. The predictive ability of the RA risk score was validated in 71 bone or soft tissue sarcoma clinical samples. These results indicated that RA-based classification could distinguish sarcoma patients with different clinical outcomes and immune statuses, which may help to explore better treatment decision-making for sarcoma patients.
first_indexed 2024-12-10T19:29:29Z
format Article
id doaj.art-889568d0739f47a4b3d473736d41f828
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-10T19:29:29Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-889568d0739f47a4b3d473736d41f8282022-12-22T01:36:17ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-02-01910.3389/fcell.2021.780951780951Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in SarcomaHuaiYuan Xu0JinXin Hu1YiJiang Song2HongMin Chen3YanYang Xu4ChuangZhong Deng5Hao Wu6GuoHui Song7JinChang Lu8QinLian Tang9LiangPing Xia10Jin Wang11XiaoJun Zhu12Department of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaVIP Department, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaGrowing evidence indicates a link between retinoic acid (RA) metabolism and sarcoma progression or immunity in laboratory studies. However, a comprehensive analysis of RA abnormality in the sarcoma population is still lacking. Herein, we systematically analyzed the molecular features of 19 retinoic acid metabolism-related enzymes and sarcoma patients’ clinical information based on TCGA/TARGET/GSE datasets. We identified two RA expression subtypes, which were related to distinct clinical survival outcomes and exhibited different biological features. Gene set enrichment analysis indicated a set of immune pathways were enriched in G1 while oncogenic pathways were enriched in G2. Immune cell infiltration analysis using the TIMER algorithm revealed more CD4+ and CD8+ T cell infiltration in G1 subgroups than in G2. Moreover, we generated a seven genes signature to predict the RA metabolism index based on the LASSO-penalized Cox regression model. Survival analysis demonstrated the significant prognostic differences between high- and low-risk groups among different bone and soft tissue datasets. A higher risk index was associated with less T cell CD8+ infiltration. The predictive ability of the RA risk score was validated in 71 bone or soft tissue sarcoma clinical samples. These results indicated that RA-based classification could distinguish sarcoma patients with different clinical outcomes and immune statuses, which may help to explore better treatment decision-making for sarcoma patients.https://www.frontiersin.org/articles/10.3389/fcell.2021.780951/fullretinoic acid metabolismsarcomaLASSO-penalized cox regressionimmuneCD8+ T cell
spellingShingle HuaiYuan Xu
JinXin Hu
YiJiang Song
HongMin Chen
YanYang Xu
ChuangZhong Deng
Hao Wu
GuoHui Song
JinChang Lu
QinLian Tang
LiangPing Xia
Jin Wang
XiaoJun Zhu
Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
Frontiers in Cell and Developmental Biology
retinoic acid metabolism
sarcoma
LASSO-penalized cox regression
immune
CD8+ T cell
title Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
title_full Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
title_fullStr Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
title_full_unstemmed Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
title_short Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
title_sort retinoic acid metabolism related enzyme signature identified prognostic and immune characteristics in sarcoma
topic retinoic acid metabolism
sarcoma
LASSO-penalized cox regression
immune
CD8+ T cell
url https://www.frontiersin.org/articles/10.3389/fcell.2021.780951/full
work_keys_str_mv AT huaiyuanxu retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT jinxinhu retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT yijiangsong retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT hongminchen retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT yanyangxu retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT chuangzhongdeng retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT haowu retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT guohuisong retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT jinchanglu retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT qinliantang retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT liangpingxia retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT jinwang retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma
AT xiaojunzhu retinoicacidmetabolismrelatedenzymesignatureidentifiedprognosticandimmunecharacteristicsinsarcoma